JUL 10, 2017 3:59 PM PDT

Protection from Zika Virus for A Defenseless Fetus

WRITTEN BY: Kara Marker

A malaria drug, called hydroxycholorquine, prevents Zika virus - even when a mother is already infected - from crossing the placenta and reaching the fetus. While researchers still need to ensure that long-term use of the drug is safe for pregnant women, this new finding could greatly help protect babies from the deleterious effects of a Zika virus infection.

Human placental cells (blue) infected with Zika virus (green) responded to the malaria drug chloroquine (left). Credit: Bin Cao

In addition to treating and preventing malaria, hydroxychloroquine is used to treat symptoms of autoimmune diseases like rheumatoid arthritis and lupus. For Zika virus, scientists all over the world are looking for preventative and therapeutic options for those infected, but so far no treatments have been approved for pregnant women.

"[Hydroxychloroquine] already is used in pregnant women to treat malaria, and we suggest that it warrants evaluation in primates and women to diminish the risks of Zika infection and disease in developing fetuses,” said senior author Indira Mysorekar, PhD, of a new study from the Washington University School of Medicine.

Pregnant women who contract Zika can spread the infection to the fetus, which are then born with a condition called microcephaly, “an indicator of neurological damage.” The immune system of a pregnant woman has its own methods of protecting the fetus, mainly a cellular process called autophagy where the body eliminates waste and pathogens from the body. While this may prevent other pathogens from crossing the placenta and reaching the fetus, Zika virus is undeterred.

Mysorekar investigated Zika’s journey across the placenta, looking for what the virus was doing that other pathogens weren’t capable of doing. Researchers saw that genes involved in the autophagy processed were activated in response to the presence of Zika virus. But in this case, autophagy promoted the Zika infection instead of suppressing it.

Researchers observed this phenomenon when they gave Zika-infected cells autophagy-promoting drugs. "It appears that Zika virus takes advantage of the autophagy process in the placenta to promote its survival and infection of placental cells," explained postdoctoral fellow and researcher on the project Bin Cao, PhD.

This is where the malaria drug hydroxychloroquine comes into play; the drug suppresses autophagy, limiting Zika virus’s ability to manipulate the body’s protective mechanisms.

While hydroxychloroquine is safely used in pregnant women, the extent to its safety is only known for temporary usage. Long-term dependence on this drug for protection of or treatment for Zika virus would be necessary for many women living in high-risk environments, and the safety of long-term hydroxychloroquine use still needs to be confirmed.

We would urge caution but nevertheless feel our study provides new avenues for feasible therapeutic interventions," Mysorekar said. "Our study suggests that an autophagy-based therapeutic intervention against Zika may be warranted in pregnant women infected with Zika virus."

The present study was published in The Journal of Experimental Medicine.

Sources: Drugs.com, Washington University School of Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 16, 2021
Immunology
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
DEC 16, 2021
Just Add Water: Super Stable Freeze-Dried COVID Vaccines
  In the face of a viral threat with pandemic potential, developing a potent vaccine is just one half of the battle ...
DEC 23, 2021
Immunology
Double Whammy Cytokine Hit Stops Transplant Side Effects
DEC 23, 2021
Double Whammy Cytokine Hit Stops Transplant Side Effects
  Patients who receive bone marrow or stem cell transplants are offered the gift of a new lease of life. However, s ...
JAN 06, 2022
Health & Medicine
New Hope for Hair Regrowth in Alopecia Areata
JAN 06, 2022
New Hope for Hair Regrowth in Alopecia Areata
Two recently completed phase 3 clinical trials showed the drug baricitinib leads to hair growth for alopecia areata pati ...
JAN 18, 2022
Immunology
Humanized Mice Reveal the Origins of Lung Immune Cells
JAN 18, 2022
Humanized Mice Reveal the Origins of Lung Immune Cells
Viruses such as coronaviruses can be transmitted when an infected person coughs, sneezes, or talks. Cells called macroph ...
Loading Comments...